Chair of Pharmaceutical Biotechnology, LMU Munich (2001-). Group Leader at IMP Vienna (1988-1995), Director Cancer Vaccines at BI Austria (1992-2001) first-in-world polymer-based gene therapy (1994). Academician EurASc, CRS College of Fellows, 522 publications, 54 416 citations, h-index 116 (GS).